Trump Says He’s Taking Hydroxychloroquine Preventatively

SMG/Zuma

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

For weeks, President Trump has been touting the anti-malarial medication hydroxychloroquine as a “miracle drug” for treating COVID-19. On Monday, he admitted that he has been taking it prophylactically for a week and a half.

“A lot of good things have come out about the hydroxy,” he said. “I happen to be taking it. I happen to be taking it.” 

Trump slipped the revelation in at the end of a “roundtable with restaurant executives and industry leaders” in which he railed against the whistleblower who revealed the Trump–Ukraine scandal and defended Secretary of State Mike Pompeo’s alleged habit of having a staffer perform household tasks. (Trump’s justification? “Maybe his wife isn’t there.”) But of all the absurd things Trump said, his purported use of a non-approved drug for an illness he doesn’t have takes the cake.

When asked for evidence of the drug’s efficacy, Trump replied, “Here’s my evidence: I get a lot of positive calls about it.” 

The drug, which is used to treat lupus and arthritis, has not been proven to be effective in treating COVID-19, though a clinical trial is underway. In an observational study of hospitalized COVID-19 patients published in the New England Journal of Medicine, researchers found that “hydroxychloroquine administration was not associated with either a greatly lowered or an increased risk of the composite end point of intubation or death” and noted that randomized, controlled trials are still needed. The Food and Drug Administration has warned against its use outside of hospital settings.

Watch the video below:

Dear Reader,

This feels like the most important fundraising drive since I've been CEO of Mother Jones, with staggeringly high stakes and so much uncertainty. In "News Is Just Like Waste Management," I try to unpack the reality we all face and how we can rise to the challenge. If you're able to, this is a critical moment to support Mother Jones’ nonprofit journalism: We need to raise $400,000 to help cover the vital reporting projects we have planned, and right now is no time to pull back.

Monika Bauerlein, CEO, Mother Jones

Dear Reader,

This feels like the most important fundraising drive since I've been CEO of Mother Jones, with staggeringly high stakes and so much uncertainty. In "News Is Just Like Waste Management," I try to unpack the reality we all face and how we can rise to the challenge. If you're able to, this is a critical moment to support Mother Jones’ nonprofit journalism: We need to raise $400,000 to help cover the vital reporting projects we have planned, and right now is no time to pull back.

Monika Bauerlein, CEO, Mother Jones

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate